These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29739083)

  • 1. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
    Chen Y; Wang X; Zhu X; Shao S
    Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
    Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
    J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma.
    Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L
    Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma.
    Gao Y; Zhao H; Lu Y; Li H; Yan G
    Tumour Biol; 2014 Nov; 35(11):11041-50. PubMed ID: 25095976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
    Liu S; Deng X; Zhang J
    Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
    Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
    Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
    Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
    Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.
    Wang C; Hu J; Lu M; Gu H; Zhou X; Chen X; Zen K; Zhang CY; Zhang T; Ge J; Wang J; Zhang C
    Sci Rep; 2015 Jan; 5():7610. PubMed ID: 25556603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.
    Fedorko M; Stanik M; Iliev R; Redova-Lojova M; Machackova T; Svoboda M; Pacik D; Dolezel J; Slaby O
    Int J Mol Sci; 2015 Sep; 16(10):23382-9. PubMed ID: 26426010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Role of MicroRNA-375 as Biomarker in Human Cancers Detection: A Meta-Analysis.
    Yan J; She Q; Shen X; Zhang Y; Liu B; Zhang G
    Biomed Res Int; 2017; 2017():1875843. PubMed ID: 29259977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma.
    Zhao A; Li G; Péoc'h M; Genin C; Gigante M
    Exp Mol Pathol; 2013 Feb; 94(1):115-20. PubMed ID: 23064048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic significance of miRNAs as potential biomarkers for human renal cell carcinoma: a systematic review and meta-analysis.
    Gu Y; Yuan J
    Expert Rev Anticancer Ther; 2022 Apr; 22(4):437-444. PubMed ID: 35255782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
    Yap NY; Yap FN; Perumal K; Rajandram R
    Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
    [No Abstract]   [Full Text] [Related]  

  • 15. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Yang X; Zeng Z; Hou Y; Yuan T; Gao C; Jia W; Yi X; Liu M
    PLoS One; 2014; 9(2):e88745. PubMed ID: 24551148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis.
    Huynh KQ; Le AT; Phan TT; Ho TT; Pho SP; Nguyen HT; Le BT; Nguyen TT; Nguyen ST
    Oxid Med Cell Longev; 2023; 2023():8379231. PubMed ID: 37122536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
    Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
    Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
    Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
    Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma.
    Huang G; Li H; Wang J; Peng X; Liu K; Zhao L; Zhang C; Chen X; Lai Y; Ni L
    Pathol Res Pract; 2020 Nov; 216(11):153152. PubMed ID: 32823234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of MicroRNA-18a for Gastric Cancer: a Meta-Analysis.
    Liang Q; Zhang G; Wang J; Sheng S
    Clin Lab; 2018 Jan; 64(1):177-184. PubMed ID: 29479894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.